Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients-Reference-Cited by-同舟云学术

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients

Published:2007-04-18 Issue:1 Volume:7 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Cesaro Simone,Giacchino Mareva,Locatelli Franco,Spiller Monica,Buldini Barbara,Castellini Claudia,Caselli Desireè,Giraldi Eugenia,Tucci Fabio,Tridello Gloria,Rossi Mario Renato,Castagnola Elio

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-7-28/fulltext.html

Reference42 articles.

1. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW: Trends in mortality due to invasive mycotic diseases in the United States, 1980–1997. Clin Infect Dis. 2001, 33: 641-647. 10.1086/322606.

2. Marr K, Carter R, Crippa F, Wald A, Corey L: Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002, 34: 909-907. 10.1086/339202.

3. Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW: Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol. 2005, 43 (S1): S49-S58. 10.1080/13693780400020113.

4. Lin SJ, Schranz J, Teusch SM: Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001, 32: 358-366. 10.1086/318483.

5. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002, 347: 408-415. 10.1056/NEJMoa020191.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of Antimicrobial-Associated Acute Kidney Injury in Children: A Structured Review;Pediatric Drugs;2023-12-13

2. Antifungal Combination Therapy for Invasive Fungal Infections in Pediatric Leukemia Patients: An Observational Cohort Study;Journal of Dr Behcet Uz Children s Hospital;2023-03-30

3. Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children;Antimicrobial Agents and Chemotherapy;2022-07-19

4. Antifungal Combination Therapy in Children with Cancer—A 4-Year Analysis of Real-Life Data of Two Major Pediatric Cancer Centers;Journal of Fungi;2021-07-26

5. Invasive Pulmonary Aspergillosis;Seminars in Respiratory and Critical Care Medicine;2020-01-30